|
WO2021074930A1
|
|
Nitrogen containing bicyclic compounds
|
|
WO2021014468A1
|
|
Blister package for improved patient compliance
|
|
WO2020021575A1
|
|
Pharmaceutical compositions and methods
|
|
WO2020021574A1
|
|
Pharmaceutical compositions and methods
|
|
US2019259302A1
|
|
Trainer device for an autoinjector
|
|
WO2019073371A1
|
|
Pharmaceutical composition comprising albumin-lipid hybrid nanoparticles
|
|
EP3678717A1
|
|
Autoinjector with a needle cover
|
|
WO2018234962A1
|
|
Process for o-sulfonation of 1,6-diazabicyclo[3.2.1]octane compounds
|
|
WO2018203197A1
|
|
Diazabicyclooctane derivatives comprising an oxyimino group for use as antibacterial agents
|
|
WO2018203194A1
|
|
Diazabicyclooctane derivatives comprising a quaternery ammonium group for use as antibacterial agents
|
|
WO2018193369A1
|
|
Antibacterial compositions
|
|
WO2018193368A1
|
|
Antibacterial compositions
|
|
KR20190129863A
|
|
Method for preparing a ketolide compound
|
|
WO2018154452A1
|
|
Autoinjector with a needle cover
|
|
WO2018055539A1
|
|
Pharmaceutical composition containing buffered insulin glargine and glp-1 analogue
|
|
CA3022675A1
|
|
Antibacterial compositions
|
|
WO2017216763A1
|
|
N-phenylalkoxy-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carboxamide derivatives and their use as antibacterial agents
|
|
WO2017216764A1
|
|
N-(alkanoyl)-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carbonylhydrazide derivatives and their use as antibacterial agents
|
|
EP3471724A1
|
|
Antibacterial compositions
|
|
BR112019013527A2
|
|
HETEROCYCLIC DERIVATIVES AS ANTIBACTERIAL COMPOUNDS
|
